1.ADENOSQUAMOUS CARCINOMA OF THE NASAL SEPTUM: A RARE VARIANT
Kim Yew Richard WONG ; Eyzawiah HASSAN ; Azreen Zaira ABU BAKAR ; Hafeza AHMAD ; Shamim Rahman S.M.A. ABDUL RASHEED ; Asmawiza AWANG ; Irfan MOHAMAD
Brunei International Medical Journal 2023;19():13-18
Adenosquamous carcinoma is a rare variant of squamous cell carcinoma of the nasal septum which is very aggressive and metastasise early with poor prognosis. We present a case of a gentleman who presented with left nasal septal swelling for 4 months. Examination showed a lesion at the left nasal septum extending to the dorsum of the nose and right upper lip region. Computed tomography scan of the paranasal sinuses and neck showed an enhancing lesion with ulceration at the left nasal septum, with regional metastasis to the neck. He underwent a subtotal rhinectomy, inferior maxillectomy, and bilateral modified radical neck dissection type III. Unfortunately, he succumbed to a cardiac arrest 5 days after surgery.
2.Gleason scores in prostate needle biopsy and prostatectomy specimens in prostatic adenocarcinoma: A correlation study
The Malaysian Journal of Pathology 2019;41(3):253-257
Introduction: Gleason scoring (GS) categorised prostatic adenocarcinoma into five prognostic grade
groups (PGGs); associated with different prognosis and treatment. This study aims to correlate
between Gleason scores of needle biopsies with the corresponding total prostatectomy specimens,
and to assess the relationship between the percentage of Gleason 4 tumour pattern (GP4) within
Gleason score 7 (GS7) needle biopsy groups with the pathological staging. Materials and Methods:
Seventy-eight specimens of needle prostate biopsy and its subsequent radical prostatectomy were
retrospectively studied. The GSs of the needle biopsy were compared with the corresponding
prostatectomy specimens. The percentage of GP4 in GS7 needle biopsy groups was calculated
and correlated with the pathological staging. Results: More than half (60%) of GS 6 needle biopsy
cases (PGG 1) were upgraded in the prostatectomy specimen, while the majority (80%) of the GS7
needle biopsy groups (PGG 2 and 3) remain unchanged. Cohen’s Kappa shows fair agreement in
the Gleason scoring between needle biopsies and prostatectomy specimens, K = 0.324 (95% CI,
6.94 to 7.29), p <0.0005 and in the percentage of GP4 in GS7 needle biopsy groups and their
corresponding radical prostatectomy specimens, K = 0.399 (95% CI 34.2 – 49.2), p<0.0005. A
significant relationship was seen between the percentage of GP4 in GS7 needle biopsy with the
pT and pN stage of its radical prostatectomy (p = 0.008 and p=0.001 respectively). Conclusion: A
higher percentage of GP4 in GS7 tumour is associated with worse tumour behaviour, therefore it
is crucial for clinicians to realise this in deciding the optimal treatment.
Result Analysis
Print
Save
E-mail